Patents by Inventor Mitchell Lewis
Mitchell Lewis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240059691Abstract: The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in medicine; and methods of treating patients with such compounds; wherein A, W, R5, n, Z, X, Y and B are as defined herein. The present invention also relates to compounds useful as synthetic intermediates of compounds of formula (I).Type: ApplicationFiled: December 1, 2021Publication date: February 22, 2024Inventors: Mitchell Lewis CHILDS, Rebecca Louise DAVIE, Hannah Joy EDWARDS, David Michael EVANS, William Jack GREVES, Simon Teanby HODGSON, Alessandro MAZZACANI, Carl Leslie NORTH, Alicja Stela OBARA, Michael Bryan ROE, David Philip ROOKER, Michael John STOCKS, Louise Michelle BIRCH, Mark PICHOWICZ, Rachael PITTAWAY, Alun John SMITH, Adam Eric THROUP, Joseph William WRIGGLESWORTH, Xuezheng YANG, David Edward CLARK
-
Publication number: 20220289727Abstract: The present invention provides compounds of formula (I) or (Ia) compositions comprising such compounds; the use of such compounds in therapy; and methods of treating patients with such compounds; wherein A, B, n, R2, R3, R4, R5, and R6 are as defined herein.Type: ApplicationFiled: February 13, 2020Publication date: September 15, 2022Inventors: Mitchell Lewis CHILDS, Rebecca Louise DAVIE, Hannah Joy EDWARDS, David Michael EVANS, Simon Teanby HODGSON, Alessandro MAZZACANI, David Edward CLARK, Paul Stuart HINCHLIFFE, Thomas Matthew BAKER, Colin Peter SAMBROOK SMITH, Alun John SMITH, Joseph William WRIGGLESWORTH, Xuezheng YANG
-
Patent number: 10392622Abstract: A self-regulating gene expression construct comprises a single promoter in operative association with a repressor sequence (e.g., bacterial repressor lacI or gaiR), operator sequence(s) responsive to the expressed repressor protein, and a transgene. A dual-regulating construct comprises a single promoter controlling expression of a bacterial repressor sequence and a transgene, and which, in the presence of a first inducer molecule, transcribes the transgene and repressor; and a ribozyme in association with an aptamer sequence, the aptamer sequence capable of interacting with a second inducer molecule to terminate mRNA degradation by the ribozyme. Also provided are recombinant vectors or viruses containing the self-regulating or dual self-regulating constructs and cells containing the vectors. Such compositions are useful in methods of treating a diseases using gene therapy.Type: GrantFiled: July 31, 2015Date of Patent: August 27, 2019Assignee: The Trustees of the University of PennsylvaniaInventors: Mitchell Lewis, Jean Bennett, Luk Vandenberghe, Matthew Sochor, Theodore G. Drivas
-
Patent number: 9868229Abstract: Embodiments of the invention relate to injection mold components, assemblies, and molding system that include superhard materials. Such injection mold components, assemblies, and systems may decrease wear of certain injection mold components, which may result in improved productivity of the injection mold and molding systems that utilize such components.Type: GrantFiled: October 28, 2015Date of Patent: January 16, 2018Assignee: US SYNTHETIC CORPORATIONInventors: Robert Keith Judd, Terry Mitchell Lewis
-
Publication number: 20170218379Abstract: A self-regulating gene expression construct comprises a single promoter in operative association with a repressor sequence (e.g., bacterial repressor lacI or gaiR), operator sequence(s) responsive to the expressed repressor protein, and a transgene. A dual-regulating construct comprises a single promoter controlling expression of a bacterial repressor sequence and a transgene, and which, in the presence of a first inducer molecule, transcribes the transgene and repressor; and a ribozyme in association with an aptamer sequence, the aptamer sequence capable of interacting with a second inducer molecule to terminate mRNA degradation by the ribozyme. Also provided are recombinant vectors or viruses containing the self-regulating or dual self-regulating constructs and cells containing the vectors. Such compositions are useful in methods of treating a diseases using gene therapy.Type: ApplicationFiled: July 31, 2015Publication date: August 3, 2017Inventors: Mitchell LEWIS, Jean BENNETT, Luk VANDENBERGHE, Matthew SOCHOR, Theodore G. DRIVAS
-
Publication number: 20160046042Abstract: Embodiments of the invention relate to injection mold components, assemblies, and molding system that include superhard materials. Such injection mold components, assemblies, and systems may decrease wear of certain injection mold components, which may result in improved productivity of the injection mold and molding systems that utilize such components.Type: ApplicationFiled: October 28, 2015Publication date: February 18, 2016Inventors: Robert Keith Judd, Terry Mitchell Lewis
-
Patent number: 9199400Abstract: Embodiments of the invention relate to injection mold components, assemblies, and molding system that include superhard materials. Such injection mold components, assemblies, and systems may decrease wear of certain injection mold components, which may result in improved productivity of the injection mold and molding systems that utilize such components.Type: GrantFiled: March 4, 2014Date of Patent: December 1, 2015Assignee: US SYNTHETIC CORPORATIONInventors: Robert Keith Judd, Terry Mitchell Lewis
-
Publication number: 20140183788Abstract: Embodiments of the invention relate to injection mold components, assemblies, and molding system that include superhard materials. Such injection mold components, assemblies, and systems may decrease wear of certain injection mold components, which may result in improved productivity of the injection mold and molding systems that utilize such components.Type: ApplicationFiled: March 4, 2014Publication date: July 3, 2014Applicant: US SYNTHETIC CORPORATIONInventors: Robert Keith Judd, Terry Mitchell Lewis
-
Patent number: 8702412Abstract: Embodiments of the invention relate to injection mold components, assemblies, and molding system that include superhard materials. Such injection mold components, assemblies, and systems may decrease wear of certain injection mold components, which may result in improved productivity of the injection mold and molding systems that utilize such components.Type: GrantFiled: May 3, 2012Date of Patent: April 22, 2014Assignee: US Synthetic CorporationInventors: Robert Keith Judd, Terry Mitchell Lewis
-
Publication number: 20120213884Abstract: Embodiments of the invention relate to injection mold components, assemblies, and molding system that include superhard materials. Such injection mold components, assemblies, and systems may decrease wear of certain injection mold components, which may result in improved productivity of the injection mold and molding systems that utilize such components.Type: ApplicationFiled: May 3, 2012Publication date: August 23, 2012Applicant: US SYNTHETIC CORPORATIONInventors: Robert Keith Judd, Terry Mitchell Lewis
-
Publication number: 20080289156Abstract: A zipper construction includes first and second fabric pieces. Each of the first and second fabric pieces includes an inner edge to which teeth are affixed. The first and second fabric pieces are formed of a weave defined by pre-dyed warp fibers formed of a substantially inelastic material and weft fibers that are formed of an elastic material. The zipper construction also includes a slider that engages the teeth of the first and second fabric pieces.Type: ApplicationFiled: May 23, 2008Publication date: November 27, 2008Inventors: Mitchell Lewis, Richard Schiff
-
Patent number: 5683356Abstract: A compound or composition incorporating silver carbonate is for use in removing excess hydrogen ions in a patient. The silver carbonate reacts with chloride ions which naturally occur in the patient's body fluids to produce a silver chloride precipitate. The chemical reaction producing silver chloride causes the release of hydroxyl, carbonate and/or bicarbonate ions which react with free hydrogen ions to form carbon dioxide and water. The silver carbonate compound or composition may be provided in a blood filtration cartridge, syringe or an orally ingestible form either alone or surrounded by a selectively permeable membrane. The membrane is selected to permit movement of ions, as well as carbon dioxide and water molecules therethrough, while preventing the silver carbonate or silver chloride precipitate from being released into the patient.Type: GrantFiled: July 1, 1996Date of Patent: November 4, 1997Assignee: Rossmark Medical Publishers Inc.Inventors: Mitchell Lewis Halperin, Surinder Cheema-Dhadli